MRSD: a novel quantitative approach for assessing suitability of RNA-seq in the clinical investigation of mis-splicing in Mendelian disease
View ORCID ProfileCharlie F. Rowlands, Algy Taylor, Gillian Rice, View ORCID ProfileNicola Whiffin, View ORCID ProfileHildegard Nikki Hall, View ORCID ProfileWilliam G. Newman, View ORCID ProfileGraeme C.M. Black, kConFab Investigators, View ORCID ProfileRaymond T. O’Keefe, View ORCID ProfileSimon Hubbard, Andrew G.L. Douglas, View ORCID ProfileDiana Baralle, View ORCID ProfileTracy A. Briggs, View ORCID ProfileJamie M. Ellingford
doi: https://doi.org/10.1101/2021.03.19.21253973
Charlie F. Rowlands
1Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
2Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
Algy Taylor
2Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
Gillian Rice
1Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Nicola Whiffin
3Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK
Hildegard Nikki Hall
4MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
William G. Newman
1Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
2Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
Graeme C.M. Black
1Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
2Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
5Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia
6kConFab, Research Department, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia
Raymond T. O’Keefe
1Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Simon Hubbard
1Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Andrew G.L. Douglas
7Wessex Clinical Genetics Service, Princess Anne Hospital, University Hospital Southampton NHS Foundation Trust, Coxford Rd, Southampton, SO16 5YA, UK
8Faculty of Medicine, University of Southampton, Duthie Building, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK
Diana Baralle
7Wessex Clinical Genetics Service, Princess Anne Hospital, University Hospital Southampton NHS Foundation Trust, Coxford Rd, Southampton, SO16 5YA, UK
8Faculty of Medicine, University of Southampton, Duthie Building, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK
Tracy A. Briggs
1Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
2Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
Jamie M. Ellingford
1Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
2Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
Posted March 20, 2021.
MRSD: a novel quantitative approach for assessing suitability of RNA-seq in the clinical investigation of mis-splicing in Mendelian disease
Charlie F. Rowlands, Algy Taylor, Gillian Rice, Nicola Whiffin, Hildegard Nikki Hall, William G. Newman, Graeme C.M. Black, kConFab Investigators, Raymond T. O’Keefe, Simon Hubbard, Andrew G.L. Douglas, Diana Baralle, Tracy A. Briggs, Jamie M. Ellingford
medRxiv 2021.03.19.21253973; doi: https://doi.org/10.1101/2021.03.19.21253973
MRSD: a novel quantitative approach for assessing suitability of RNA-seq in the clinical investigation of mis-splicing in Mendelian disease
Charlie F. Rowlands, Algy Taylor, Gillian Rice, Nicola Whiffin, Hildegard Nikki Hall, William G. Newman, Graeme C.M. Black, kConFab Investigators, Raymond T. O’Keefe, Simon Hubbard, Andrew G.L. Douglas, Diana Baralle, Tracy A. Briggs, Jamie M. Ellingford
medRxiv 2021.03.19.21253973; doi: https://doi.org/10.1101/2021.03.19.21253973
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (205)
- Cardiovascular Medicine (2966)
- Dermatology (251)
- Emergency Medicine (445)
- Epidemiology (12797)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4616)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2940)
- Health Policy (1072)
- Hematology (393)
- HIV/AIDS (931)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4396)
- Nursing (238)
- Nutrition (646)
- Oncology (2288)
- Ophthalmology (651)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6988)
- Radiology and Imaging (1541)
- Respiratory Medicine (919)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)